Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5589 ARTÍCULOS , VIENDO DEL 5146 AL 5160
Tuma Santos CA, Wallace WD, Kim S, Vijayakumar V.
J Nucl Med Technol. 2021 Jun;49(2):114-119. doi: 10.2967/jnmt.120.258491. Epub 2020 Dec 24.
Imaging Transcriptomics in Neurodegenerative Diseases
Mroczek M, Desouky A, Sirry W.
J Neuroimaging. 2021 Mar;31(2):244-250. doi: 10.1111/jon.12827. Epub 2020 Dec 26.
Freezing of Gait in Parkinson's Disease: Invasive and Noninvasive Neuromodulation
Rahimpour S, Gaztanaga W, Yadav AP, Chang SJ, Krucoff MO, Cajigas I, Turner DA, Wang DD.
Neuromodulation. 2021 Jul;24(5):829-842. doi: 10.1111/ner.13347. Epub 2020 Dec 26.
Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies
Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS, Zang YF, Xiang YT.
CNS Neurosci Ther. 2021 Mar;27(3):270-279. doi: 10.1111/cns.13549. Epub 2020 Dec 28.
Zhang R, Li J, Wu Y, Liang S, Xu L.
Genet Test Mol Biomarkers. 2021 Jan;25(1):20-30. doi: 10.1089/gtmb.2020.0195. Epub 2020 Dec 28.
Targeting mitophagy in Parkinson's disease
Clark EH, Vázquez de la Torre A, Hoshikawa T, Briston T.
J Biol Chem. 2021 Jan-Jun;296:100209. doi: 10.1074/jbc.REV120.014294. Epub 2020 Dec 24.
Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders
Rusz J, Tykalova T, Ramig LO, Tripoliti E.
Mov Disord. 2021 Apr;36(4):803-814. doi: 10.1002/mds.28465. Epub 2020 Dec 29.
Interactions of α-synuclein oligomers with lipid membranes
Musteikytė G, Jayaram AK, Xu CK, Vendruscolo M, Krainer G, Knowles TPJ.
Biochim Biophys Acta Biomembr. 2021 Apr 1;1863(4):183536. doi: 10.1016/j.bbamem.2020.183536. Epub 2020 Dec 26.
Consensus Guidelines on Rodent Models of Restless Legs Syndrome
Salminen AV, Silvani A, Allen RP, Clemens S, Garcia-Borreguero D, Ghorayeb I, Ferré S, Li Y, Ondo W, Picchietti DL, Rye D, Siegel JM, Winkelman JW, Manconi M; International Restless Legs Syndrome Study Group (IRLSSG).
Mov Disord. 2021 Mar;36(3):558-569. doi: 10.1002/mds.28401. Epub 2020 Dec 31.
Efficacy of Vestibular Rehabilitation in Patients With Neurologic Disorders: A Systematic Review
Tramontano M, Russo V, Spitoni GF, Ciancarelli I, Paolucci S, Manzari L, Morone G.
Arch Phys Med Rehabil. 2021 Jul;102(7):1379-1389. doi: 10.1016/j.apmr.2020.11.017. Epub 2020 Dec 28.
Functional relevance of resistance training-induced neuroplasticity in health and disease
Hortobágyi T, Granacher U, Fernandez-Del-Olmo M, Howatson G, Manca A, Deriu F, Taube W, Gruber M, Márquez G, Lundbye-Jensen J, Colomer-Poveda D.
Neurosci Biobehav Rev. 2021 Mar;122:79-91. doi: 10.1016/j.neubiorev.2020.12.019. Epub 2020 Dec 28.
Research on developing drugs for Parkinson's disease
Zhang CL, Han QW, Chen NH, Yuan YH.
Brain Res Bull. 2021 Mar;168:100-109. doi: 10.1016/j.brainresbull.2020.12.017. Epub 2020 Dec 30.
Safinamide in neurological disorders and beyond: Evidence from preclinical and clinical studies
Wasan H, Singh D, Kh R.
Brain Res Bull. 2021 Mar;168:165-177. doi: 10.1016/j.brainresbull.2020.12.018. Epub 2020 Dec 30.
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study
Bullock A, Kaul I, Li S, Silber C, Doherty J, Kanes SJ.
J Neurol Sci. 2021 Feb 15;421:117277. doi: 10.1016/j.jns.2020.117277. Epub 2020 Dec 20.
Polydopamine-based nanomaterials and their potentials in advanced drug delivery and therapy
Li H, Yin D, Li W, Tang Q, Zou L, Peng Q.
Colloids Surf B Biointerfaces. 2021 Mar;199:111502. doi: 10.1016/j.colsurfb.2020.111502. Epub 2020 Dec 17.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.